SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-15-025168
Filing Date
2015-03-11
Accepted
2015-03-11 16:17:17
Documents
1
Period of Report
2012-08-08

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3330
  Complete submission text file 0001209191-15-025168.txt   4816
Mailing Address 3101 WESTERN AVENUE SUITE 600 SEATTLE WA 98121
Business Address 3101 WESTERN AVENUE SUITE 600 SEATTLE WA 98121 2062827100
CTI BIOPHARMA CORP (Issuer) CIK: 0000891293 (see all company filings)

IRS No.: 911533912 | State of Incorp.: WA | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 617 W 168TH ST ROOM 139 C/O COLUMBIA UNIV OF NURSING NEW YORK NY 10032
Business Address
MUNDINGER MARY ONEIL (Reporting) CIK: 0001179980 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-12465 | Film No.: 15692750